CE14 - Physiologie et physiopathologie 2021

Hepatic nuclear receptor networks controlling responses to nutritional challenges – Hepatologic

Submission summary

The liver orchestrates metabolic response to fasting through potent transcriptional regulations. Peroxisome Proliferator-Activated Receptor alpha (PPARa) and the Glucocorticoid Receptor (GR) are pivotal transcription factors in these adaptive processes. They control a network of genes, including Retinol Saturase (RetSat) and Fibroblast Growth Factor 21 (FGF21), to ensure systemic energy homeostasis. Our project is divided in 3 aims: Aim 1 applies unbiased genomic approaches to define the molecular cross-talk between PPARa and GR during fasting and diet-induced obesity; Aim 2 targets the contributions of hepatocyte RetSat and Fgf21 to these metabolic responses. Aim 3 investigates the functional role of these receptors and transcriptional targets in the beneficial effects of time-restricted feeding for diet-induced metabolic diseases. Our project will generate mechanistic insights into the response to fasting and its potential as a target for the treatment of metabolic diseases.

Project coordination

Hervé Guillou (Institut National de la Recherche pour l’Agriculture, l’Alimentation et l’Environnement Centre Occitanie-Toulouse)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partnership

INRAE TOXALIM - TIM Institut National de la Recherche pour l’Agriculture, l’Alimentation et l’Environnement Centre Occitanie-Toulouse
TUM School of Life Sciences / Metabolic Programming
INSERM Institut Cochin
Charité University Medicine / Institute of Pharmacology Center for Cardiovascular Research, CCR

Help of the ANR 355,000 euros
Beginning and duration of the scientific project: April 2022 - 36 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter